Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives
L. Zou, P. Spanogiannopoulos, H.-C. Chien, L. M. Pieper, W. Cai, N. Khuri, J. Pottel, B. Vora, Z. Ni, E. Tsakalozou, W. Zhang, B. K. Shoichet, K. M. Giacomini, P. J. Turnbaugh
Abstract
Food and drugs contain diverse small molecule additives (excipients) with unclear impacts on human physiology. Here, we evaluate their potential impact on intestinal absorption, screening 136 unique compounds for inhibition of the key transporter OATP2B1. We identified and validated 24 potent OATP2B1 transport inhibitors, characterized by higher molecular weight and hydrophobicity compared to poor or non-inhibitors. OATP2B1 inhibitors were also enriched for dyes, including 8 azo (R-N=N-R') dyes. Pharmacokinetic studies in mice confirmed that FD&C Red No. 40, a common azo dye excipient, inhibited drug absorption; however, the human gut microbiome inactivated azo dye excipients, producing metabolites that no longer inhibit OATP2B1 transport. These results support a beneficial role for the microbiome in limiting the unintended effects of food and drug additives in the intestine. One Sentence SummaryFood and drug additives inhibit intestinal drug transporters, although some are inactivated by gut bacterial metabolism.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors
T. S. Kyaw, M. Sandy, … P. J. Turnbaugh·bioRxiv·Oct 13, 2022
- Dicloxacillin and flucloxacillin inhibit hepatic uptake transporters - in vitro investigations and physiological based pharmacokinetic modelling
Noora Sjöstedt, Ogochukwu Ukamaka Amaeze, … Erkka Järvinen·Clinical and Translational SciencePeer-reviewed·Feb 1, 2026
- Influence of Gut Microbiota on Oral Drug Absorption and Metabolism
Douglas A. Nelson, Vaishnavi Veerareddy, … Karunya K. Kandimalla·bioRxiv·Feb 16, 2025
- Gut bacteria generate prodrugs in situ increasing systemic drug exposure
Ting-Hao Kuo, Anoop Singh, … Michael Zimmermann·bioRxiv·Dec 9, 2025
- Establishing an in vitro pipeline for the high-throughput quantification of epithelial permeability of gut bacterial metabolites
Amber Brauer-Nikonow, Carlos Geert Pieter Voogdt, … Michael Zimmermann·bioRxiv·Jun 10, 2025
- The global anaerobic metabolism regulator fnr is necessary for the degradation of food dyes and drugs by Escherichia coli
L. M. Pieper, P. Spanogiannopoulos, … P. J. Turnbaugh·bioRxiv·Oct 25, 2022